Cdc7-IN-5

Contact us
TargetMol
Product Code: TAR-T10727
Supplier: TargetMol
CodeSizePrice
TAR-T10727-1mg1mg£164.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10727-5mg5mg£303.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10727-1mL1 mL * 10 mM (in DMSO)£325.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10727-10mg10mg£454.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10727-25mg25mg£704.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10727-50mg50mg£938.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T10727-100mg100mg£1,259.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1
❮❯

Documents

Further Information

Bioactivity:
Cdc7-IN-5 is a potent inhibitor of Cdc7 kinase extracted from patent WO2019165473A1 (compound I-B).
CAS:
1402057-86-6
Formula:
C25H23N3O5
Molecular Weight:
445.475
Pathway:
Cell Cycle/Checkpoint
Purity:
0.98
SMILES:
CCOC(=O)C1=C(OC(=C/c2c[nH]c3ncccc23)C1=O)N1CCc2ccc(OC)cc2C1
Target:
CDK

References

1. Christian Andrew HASSIG, et al. Methods of treatment of cancer comprising cdc7 inhibitors. WO2019165473A1.